Aussie panel questions Trump's drug use

By Tracey Ferrier
Updated May 19 2020 - 2:26pm, first published 2:21pm
There's no data the benefit of the malaria drug President Trump is taking would outweigh its risks.
There's no data the benefit of the malaria drug President Trump is taking would outweigh its risks.

There's simply not enough evidence to support Donald Trump's use of a malaria drug to protect himself against COVID-19, an Australian coronavirus task force says.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Scone news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.